Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.8M Buy
590,580
+5,163
+0.9% +$572K 0.32% 61
2025
Q4
$64.6M Buy
585,417
+25,918
+5% +$2.85M 0.34% 56
2025
Q3
$62.4M Sell
559,499
-59,779
-10% -$6.28M 0.4% 48
2025
Q2
$65.4M Buy
619,278
+119,155
+24% +$12.5M 0.5% 36
2025
Q1
$55M Buy
500,123
+82,428
+20% +$8.74M 0.58% 31
2024
Q4
$43.2M Buy
417,695
+156,777
+60% +$17.1M 0.52% 40
2024
Q3
$29.3M Buy
260,918
+123,793
+90% +$12.6M 0.56% 29
2024
Q2
$12.3M Buy
137,125
+117,759
+608% +$10.1M 0.54% 37
2024
Q1
$1.68M Buy
19,366
+10,591
+121% +$868K 0.23% 90
2023
Q4
$730K Buy
+8,775
New +$707K 0.18% 129

Other funds holding AFL

&Partners's AFL Position: Q1 2026 in Review

&Partners increased its Aflac (AFL) stake by 0.88% in Q1 2026, buying an estimated $572K and bringing the position to 590,580 shares worth $64.8M. The position accounts for 0.32% of the portfolio, ranked #61.

&Partners first reported a position in AFL in Q4 2023 and has held it in 10 quarters since. The position peaked at $65.4M in Q2 2025. 1,653 funds tracked by Wall St. Rank hold AFL as of Q1 2026.

  • &Partners held 590,580 shares of Aflac worth $64.8M as of Q1 2026.
  • &Partners bought 5,163 Aflac shares in Q1 2026, an estimated $572K.
  • Aflac made up 0.32% of &Partners's portfolio in Q1 2026, its #61 holding.
  • &Partners first reported a position in Aflac in Q4 2023 and has held it in 10 quarters since.
  • &Partners's Aflac position peaked at $65.4M in Q2 2025.
  • 1,653 funds tracked by Wall St. Rank held Aflac as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.